|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
1997-6-18
|
|
pubmed:abstractText |
To assess nuclear activity by DNA flow cytometry (FCM), Gleason score and serum prostate-specific antigen (PSA) levels in predicting extracapsular tumour involvement in patients with prostate cancer.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0147-958X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
20
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
119-26
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:9088668-Cell Division,
pubmed-meshheading:9088668-DNA, Neoplasm,
pubmed-meshheading:9088668-Diploidy,
pubmed-meshheading:9088668-Flow Cytometry,
pubmed-meshheading:9088668-Humans,
pubmed-meshheading:9088668-Male,
pubmed-meshheading:9088668-Neoplasm Staging,
pubmed-meshheading:9088668-Prostate-Specific Antigen,
pubmed-meshheading:9088668-Prostatic Neoplasms,
pubmed-meshheading:9088668-Retrospective Studies,
pubmed-meshheading:9088668-Treatment Outcome
|
|
pubmed:year |
1997
|
|
pubmed:articleTitle |
DNA cytometric proliferative index predicting organ confinement in clinical stage-B prostate cancer.
|
|
pubmed:affiliation |
Department of Pathology, University of Western Ontario, London. moussa1@julian.uwo.ca
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
